多囊肝肾病或先天性心脏病中肝联合肾或心脏多器官移植的问题:当前实践与免疫学方面
综述多囊肝肾病中肝肾联合移植及先天性心脏病(尤其Fontan术后)中心肝联合移植的适应证、时机、手术方面与结局,并总结肝移植物对同期移植器官免疫保护作用的证据及潜在机制。
要点
- 多囊肝肾病患者可考虑肝肾联合移植,需评估适应证与结局。
- 先天性心脏病及心源性肝硬化成年患者,尤其Fontan术后,肝移植团队需面对心肝联合移植问题。
- 肝移植物对同期移植器官具有免疫保护作用,综述总结了相关证据与潜在机制。
核心结论
- 综述了多囊肝肾病中肝肾联合移植的适应证与结局,以及心肝联合移植的适应证、时机和手术方面。
- 总结了肝移植物对同期移植器官免疫保护作用的证据及潜在机制。
研究设计与样本
- 综述,检索范围未在摘要中报告。
主要发现
- 多囊肾和肝患者可能通过多器官移植进行管理。
- 随着先天性心脏病和心源性肝硬化患者存活至成年,尤其Fontan术后,肝移植团队预计将面对心肝联合移植相关问题。
- 综述总结了肝同种移植物对同期移植器官免疫保护影响的证据和潜在机制。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Solid organ transplantation has become an integral part of the management of patients with end-stage diseases of the kidney, liver, heart and lungs. Most procedures occur in isolation, but multi-organ transplantation of the liver with either the kidney or heart has become an option. As more patients with congenital heart disease and cardiac cirrhosis survive into adulthood, particularly after the Fontan procedure, liver transplant teams are expected to face questions regarding multi-organ (heart-liver) transplantation. Similarly, patients with polycystic kidneys and livers may be managed by multi-organ transplantation. Herein, we review the indications and outcomes of simultaneous liver-kidney transplantation for polycystic liver-kidney disease, and discuss the indications, timing and procedural aspects of combined heart-liver transplantation. We also summarise the evidence for, and potential mechanisms underlying, the immunoprotective impact of liver allografts on the simultaneously transplanted organs.
引用
- Taner T, Hilscher MB, Broda CR, et al. Issues in multi-organ transplantation of the liver with kidney or heart in polycystic liver-kidney disease or congenital heart disease: Current practices and immunological aspects. J Hepatol. 2023. PMID: 37208103. doi:10.1016/j.jhep.2023.02.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。